Case Report
Covid-19 Acute Respiratory Distress Syndrome And Acute Myocarditis Saved With Immunoglobulin
Jebbar Nourddine1,3*, Elkaissi Jaber1,3, Diai Abdellatif1,3, Maaroufi Ayoub1,3, Jbili Nabil1,3, Bibiche Lotfi1,3, Zinebi Ali2,3 and Laoutid Jaouad1,3
1Anesthesiology & intensive care department, Moulay Ismail Military Hospital, Morocco.
2Internal Medicine Department, Moulay Ismail Military Hospital, Morocco.
3Faculty of Medicine, Sidi Mohamed Ben Abdellah University, Morocco.
Jebbar Nourddine, Anesthesiology & Intensive Care Department, Moulay Ismail Military Hospital, Morocco.
Received Date: February 07, 2021; Published Date:February 22, 2021
Abstract
The novel corona virus disease (COVID-19) becomes a major public health. It was declared as pandemic by the World Health Organization on March 12, 2020.Myocarditis and myocardial injury are considered as one of the leading causes for death of COVID-19 Patients. The use of immunoglobulin seems to have an important role in the favorable evolution of these patients with cardiac involvement.
-
Jebbar Nourddine, Elkaissi Jaber, Diai Abdellatif. Covid-19 Acute Respiratory Distress Syndrome And Acute Myocarditis Saved With Immunoglobulin. Anaest & Sur Open Access J. 2(3): 2020. ASOAJ.MS.ID.000540.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.